Drug Resistance of Imported <i>P. falciparum</i> and <i>P. vivax</i> Isolates — China, 2021–2023
The iDES and molecular surveillance of antimalarial drug resistance indicated decreasing sensitivity to current first-line treatments. Continued surveillance of antimalarial drug resistance is vital for early warning and appropriate response to the spread of resistant parasites.
Authors
- Jianping Cao (ORCID: https://orcid.org/0000-0002-1974-0047)
- Jianhai Yin (ORCID: https://orcid.org/0000-0003-1333-8732)
- Siqi Wang (ORCID: https://orcid.org/0000-0002-7121-2321)
- He Yan
- Zhigui Xia (ORCID: https://orcid.org/0000-0002-0569-0368)
- Yan Deng (ORCID: https://orcid.org/0000-0002-9793-0508)
Institutions
- Shanghai Jiao Tong University (CN)
Publication Details
- Journal
- China CDC Weekly
- Published
- 2025-01-01
- DOI
- https://doi.org/10.46234/ccdcw2025.149
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00